Ready to build and scale from the UAE?
Nawah is a six-week market entry program for deployment-ready life sciences companies evaluating the UAE as a base for international expansion. The program provides direct access to the regulators, healthcare providers, investors, infrastructure and strategic partners shaping one of the world's fastest-growing life sciences markets. Through a structured six-week journey, companies build the relationships, market understanding and strategic foundation required to enter the UAE market and pursue expansion opportunities across the GCC, Africa and South Asia.
A strategic platform for global life sciences companies
1. Regulatory Speed and Agility
Emirates Drug Establishment: 25-day fast track approval timelines
2. Population Scale Genomics and Integrated Health Data
Abu Dhabi BioBank: Capacity for 100,000 cord blood units and up to 5 million biological samples
3. Industrial Enablement and Global Market Access
Region's widest trade agreement network
Cold-chain logistics reaching 2/3 of the world within an 8-hour flight
What your company leaves with
Six weeks of structured access, followed by 90 days of support while you establish in the UAE.
Strategic access
Direct access to UAE regulators, healthcare providers, infrastructure, commercial and capital partners most relevant to your company’s stage and sector.
Market-entry pathway
Practical guidance on UAE establishment, including the regulatory, operational and infrastructure requirements for clinical or commercial deployment.
Regulatory clarity
Guidance on federal and emirate-level pathways for product approval, clinical research, manufacturing and licensing.
Cross-border reach
Understanding of UAE-to-global expansion opportunities across the GCC and Global South, alongside engagement with institutions central to regulatory, trade and logistics pathways.
Capital readiness
An introduction to the UAE’s sovereign and institutional capital landscape, including relevant government incentives and support, and how to position your company for engagement.
Ongoing support
A 90-day follow-up period with structured check-ins, warm reintroductions and targeted support to advance your UAE establishment.
The Nawah journey, week by week
Policy & Regulation
Policy and regulation for clinical trials, manufacturing and commercialization.
Clinical & Commercial
Clinical trials, procurement, distribution and commercial deployment.
Infrastructure & Logistics
Free zones, manufacturing and supply chain infrastructure.
Business & Capital
Positioning for strategic partnerships and investment.
Business & Cross-border Growth Capital
Leveraging the UAE as a base for regional and Global South expansion.
UAE Immersion
Exclusive site visits, ecosystem face-time and one-to-one meetings with program partners.
Nawah is designed for deployment-ready life sciences companies
To be considered, your company should meet all three requirements below.
Be clinical- or commercial-deployment-ready
Deployment-ready companies with technologies at an advanced stage of development, including TRL 7-9 technologies, clinical-stage assets, and commercially validated or GMP-certified platforms.
Align with one of the program's sub-pillars
(1) Digital Health & AI, (2) Pharma and MedTech Manufacturing, (3) Longevity and Precision Health.
Be able to participate fully
Committing two senior representatives to the remote sessions and to travel to theUAE for the in-person week.
Nawah is a fee-based program. Full details of participation fees and terms will be shared with shortlisted companies.
